Wolfspeed Q1 2026 Earnings Significant EPS Miss Amid Operational Scaling Challenges HCTI Q4 2025 Earnings Staggering EPS Miss Driven by Deepening Losses OBIO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline in PreRevenue Phase SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Haemonetics Q1 2026 Earnings EPS Slightly Above Estimates Stock Gains 57 Maximus MMS Q1 2026 Earnings EPS Beats Estimates Stock Slightly Down